4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-16-012536
CIK 0000875622operating
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 5:16 PM ET
Size
5.3 KB
Accession
0001062993-16-012536
Insider Transaction Report
Form 4
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-11-29$48.08/sh−10,000$480,832→ 949,973 total(indirect: See footnote)
Footnotes (2)
- [F1]The selling price of $48.0832 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.00 to $48.2501. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]These shares are held in trust on behalf of the reporting person and Ms. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 5:16 PM ET
- Size
- 5.3 KB